Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Fischer

Showing results (421-430 of 493) with videos related to

Pageof 50
Sort By:
Haematologica|January 12, 2005
Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study GroupJean Donadieu, Thierry Leblanc, Brigitte Bader Meunier, et al.
Science (New York, N.Y.)|November 7, 2009
Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophyNathalie Cartier, Salima Hacein-Bey-Abina, Cynthia C Bartholomae, et al.
Blood|October 29, 2005
Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 studySylvain Choquet, Veronique Leblond, Raoul Herbrecht, et al.
The Journal of Allergy and Clinical Immunology|June 20, 2014
Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriersClaire Aguilar, Christelle Lenoir, Nathalie Lambert, et al.
Blood|October 4, 2013
A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiencyBénédicte Neven, Emilie Mamessier, Julie Bruneau, et al.
The Journal of Allergy and Clinical Immunology|August 25, 2016
Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 childrenMarie-Louise Frémond, Mathieu Paul Rodero, Nadia Jeremiah, et al.
Blood|March 12, 2016
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineagesJean-François Emile, Oussama Abla, Sylvie Fraitag, et al.
Haematologica|October 30, 2016
Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndromeChristian Klemann, Myrian Esquivel, Aude Magerus-Chatinet, et al.
Blood|February 7, 2012
Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?Juliana F Fernandes, Vanderson Rocha, Myriam Labopin, et al.
The Journal of Allergy and Clinical Immunology|August 3, 2010
Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?Andrew R Gennery, Mary A Slatter, Laure Grandin, et al.
Pageof 50

Showing results (421-430 of 493) with videos related to

Sort By:
Pageof 50
Haematologica|January 12, 2005
Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study GroupJean Donadieu, Thierry Leblanc, Brigitte Bader Meunier, et al.
Science (New York, N.Y.)|November 7, 2009
Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophyNathalie Cartier, Salima Hacein-Bey-Abina, Cynthia C Bartholomae, et al.
Blood|October 29, 2005
Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 studySylvain Choquet, Veronique Leblond, Raoul Herbrecht, et al.
The Journal of Allergy and Clinical Immunology|June 20, 2014
Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriersClaire Aguilar, Christelle Lenoir, Nathalie Lambert, et al.
Blood|October 4, 2013
A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiencyBénédicte Neven, Emilie Mamessier, Julie Bruneau, et al.
The Journal of Allergy and Clinical Immunology|August 25, 2016
Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 childrenMarie-Louise Frémond, Mathieu Paul Rodero, Nadia Jeremiah, et al.
Blood|March 12, 2016
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineagesJean-François Emile, Oussama Abla, Sylvie Fraitag, et al.
Haematologica|October 30, 2016
Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndromeChristian Klemann, Myrian Esquivel, Aude Magerus-Chatinet, et al.
Blood|February 7, 2012
Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?Juliana F Fernandes, Vanderson Rocha, Myriam Labopin, et al.
The Journal of Allergy and Clinical Immunology|August 3, 2010
Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?Andrew R Gennery, Mary A Slatter, Laure Grandin, et al.
Pageof 50